PharmaTimes

Lundbeck gains EU orphan status for anti‑ACTH antibody

European ruling supports development in rare endocrine disorders

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients

New data reinforce daratumumab as standard of care for multiple myeloma

Long-term survival projections suggest improved outcomes for patients

Six new medicines leap towards EU approval

The recommendations include new treatments for cancer and intraocular pressure and prevention of uncomplicated flu.

Opdivo/Yervoy improves survival in pleural mesothelioma

Combination therapy showed benefit in hard-to-treat cancer type